Thomas Clozel

Thomas Clozel is the Chief Executive Officer and Co-founder of OWKIN and serves as a member of the board of directors at Université Paris-Saclay. As a non-operational co-founder, Thomas has been involved with Bioptimus and Cure51. Additionally, Thomas contributes to the XPRIZE as a member of the brain trust. Educationally, Thomas completed a research fellowship in Hematology-oncology at Joan & Sanford I. Weill Medical College of Cornell University and participated in a clinical rotation in the Neurology Department at the Icahn School of Medicine at Mount Sinai.